Kate Burton

Kate Burton is an accomplished executive in the health sector with substantial experience in leadership roles, including Executive Vice President at Edelman since February 2019, and previously Co-founder and Chief Operating Officer at MicrobiomeDX. At MicrobiomeDX, Kate contributed to innovations in cancer therapies through strategic collaborations and biomarker profiling. Prior experience includes serving as Executive Director at Premier Genomics, where Kate significantly increased revenue, and Director of Accounts and Strategy at Big Arrow Group, managing global client relationships for major pharmaceutical brands. Kate's career began in corporate communications at the American Arbitration Association and G&S Business Communications. Educationally, Kate holds an MBA in Marketing from NYU Stern School of Business and a B.A. in English and Political Science from Boston University.